Ultromics has been working with the NHS since 2017 to train, pilot and validate EchoGo, across 30 NHS sites in one of the largest echo studies of its kind.
In 2020, Ultromics received a £2.7 million grant from NHSX to fast-track EchoGo into Trusts and make it commercially available. The goal is to introduce doctors to the benefits of cloud and ease time and resource burden, whilst ensuring accuracy and eliminating variability, one of the main issues with echo diagnosis.
